兴齐眼药：目前有四条生产线具备生产0.01%硫酸阿托品滴眼液的GMP资质，现阶段产能可满足市场需求

Core Viewpoint - The company currently has four production lines certified for the production of 0.01% atropine sulfate eye drops, which are sufficient to meet current market demand. Future capacity adjustments will be made based on market demand changes [1]. Group 1 - The company has four production lines with GMP certification for 0.01% atropine sulfate eye drops [1]. - Current production capacity is adequate to satisfy market demand [1]. - The company plans to adjust production capacity and layout according to changes in market demand in the future [1].